Publications in 2023
Romero-Cabrera JL, Garcia-Rios A, Sotos-Prieto M, Quintana-Navarro G, Alcala-Diaz JF, Martin-Piedra L, Torres-Pena JD, Luque RM, Yubero-Serrano EM, Delgado-Lista J, Katsiki N, Kales SN, Lopez-Miranda J, Perez-Martinez P. Adherence to a Mediterranean lifestyle improves metabolic status in coronary heart disease patients: A prospective analysis from the CORDIOPREV study. JOURNAL OF INTERNAL MEDICINE. 2023. 574-588. DOI: 10.1111/joim.13602. IF: 11,1 Q1 D2
Blázquez-Encinas R, García-Vioque V, Caro-Cuenca T, Moreno-Montilla MT, Mangili F, Alors-Pérez E, Ventura S, Herrera-Martínez AD, Moreno-Casado P, Calzado MA, Salvatierra A, Gálvez-Moreno MA, Fernandez-Cuesta L, Foll M, Luque RM, Alcala N, Pedraza-Arevalo S, Ibáñez-Costa A, Castaño JP. Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery. JOURNAL OF TRANSLATIONAL MEDICINE. 2023. DOI: 10.1186/s12967-023-04754-8. IF: 7,4 Q1 D3
Montero-Hidalgo AJ, Perez-Gomez JM, Martinez-Fuentes AJ, Gomez-Gomez E, Gahete MD, Jimenez-Vacas JM, Luque RM. Alternative splicing in bladder cancer: potential strategies for cancer diagnosis, prognosis, and treatment. WILEY INTERDISCIPLINARY REVIEWS-RNA. 2023. DOI: 10.1002/wrna.1760. IF: 7,3 Q1 D3
Herrera-Martínez AD, Castillo-Peinado LLS, Molina-Puerta MJ, Calanas-Continente A, Membrives A, Castilla J, Cardenosa MC, Casado-Díaz A, Gálvez-Moreno MA, Gahete MD, Gómez JMQ, Bouillon R, Priego-Capote F, Luque RM. Bariatric surgery and calcifediol treatment, Gordian knot of severe-obesity-related comorbidities treatment. FRONTIERS IN ENDOCRINOLOGY. 2023. DOI: 10.3389/fendo.2023.1243906. IF: 5,2 Q1 D3
Acosta FD, Gomez EJ, Rey IB, Saucedo VR, Moyano RV, Fernandez RO. Comparing data from thrombectomy in m2 occlusion and proximal middle cerebral artery. INTERVENTIONAL NEURORADIOLOGY. 2023. 102-107. DOI: 10.1177/15910199221074881. IF: 1,7 Q4 D
Valenzuela-Molina F, Bura FI, Vazquez-Borrego MC, Granados-Rodriguez M, Rufian-Andujar B, Rufian-Pena S, Casado-Adam A, Sanchez-Hidalgo JM, Rodriguez-Ortiz L, Ortega-Salas R, Martinez-Lopez A, Michan C, Alhama J, Arjona-Sanchez A, Romero-Ruiz A. Intraoperative oxygen tension and redox homeostasis in Pseudomyxoma peritonei: A short case series. FRONTIERS IN ONCOLOGY. 2023. DOI: 10.3389/fonc.2023.1076500. IF: 4,7 Q2 D4
Pérez-Gómez JM, Porcel-Pastrana F, De La Luz-Borrero M, Montero-Hidalgo AJ, Gómez-Gómez E, Herrera-Martínez AD, Guzmán-Ruiz R, Malagón MM, Gahete MD, Luque RM. LRP10, PGK1 and RPLP0: Best Reference Genes in Periprostatic Adipose Tissue under Obesity and Prostate Cancer Conditions. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023. DOI: 10.3390/ijms242015140. IF: 5,6 Q1 D3
Fuentes-Fayos AC, G-Garcia ME, Perez-Gomez JM, Montero-Hidalgo AJ, Martin-Colom J, Doval-Rosa C, Blanco-Acevedo C, Torres E, Toledano-Delgado A, Sanchez-Sanchez R, Peralbo-Santaella E, Ortega-Salas RM, Jimenez-Vacas JM, Tena-Sempere M, Lopez M, Castano JP, Gahete MD, Solivera J, Luque RM. Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence. EBIOMEDICINE. 2023. DOI: 10.1016/j.ebiom.2023.104484. IF: 11,1 Q1 D1
Ruiz-Caceres I, Romero TH, Merino IG, Zapirain JP, Perez-Mies B, Sanchez-Conde M, Riano MA, Rubio R, Alen JF, Gonzalez AV, Anton CS, Munez E, Sanchez RS, Corona-Mata D, Ansorregui IA, Miro JM, de Obanos RBP, Ibero C, Gomez-Roman J, Farinas MC, Bello TT, de Alava E, Cisneros JM, Matias-Guiu X, Rivero A, NECROCOVID Study Grp. Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections. FRONTIERS IN MEDICINE. 2023. DOI: 10.3389/fmed.2023.1151843. IF: 3,9 Q2 D4
Pedraza-Arevalo S, Alors-Perez E, Blazquez-Encinas R, Herrera-Martinez AD, Jimenz-Vacas JM, Fuentes-Fayos AC, Reyes O, Ventura S, Sanchez-Sanchez R, Ortega-Salas R, Serrano-Blanch R, Galvez-Moreno MA, Gahete MD, Ibanez-Costa A, Luque RM, Castano JP. Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors. TRANSLATIONAL RESEARCH. 2023. 63-73. DOI: 10.1016/j.trsl.2022.07.005. IF: 7,8 Q1 D2
Alors-Pérez E, Pedraza-Arevalo S, Blázquez-Encinas R, Moreno-Montilla MT, García-Vioque V, Berbel I, Luque RM, Sainz B Jr, Ibañez-Costa A, Castaño JP. Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023. DOI: 10.1186/s13046-023-02858-z. IF: 11,3 Q1 D2
Lopez-Pedrera C, Patino-Trives AM, Cerdo T, Ortega-Castro R, Sanchez-Pareja I, Ibanez-Costa A, Munoz-Barrera L, Abalos-Aguilera MC, Ruiz-Vilchez D, Azpilcueta PS, Espinosa M, Barbarroja N, Escudero-Contreras A, Castano JP, Luque R, Ortega R, Aguirre MA, Perez-Sanchez C. Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features. JOURNAL OF AUTOIMMUNITY. 2023. DOI: 10.1016/j.jaut.2022.102990. IF: 12,8 Q1 D1
Jimenez-Vacas JM, Montero-Hidalgo AJ, Gomez-Gomez E, Saez-Martinez P, Fuentes-Fayos AC, Closa A, Gonzalez-Serrano T, Martinez-Lopez A, Sanchez-Sanchez R, Lopez-Casas PP, Sarmento-Cabral A, Olmos D, Eyras E, Castano JP, Gahete MD, Luque RM. Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes. TRANSLATIONAL RESEARCH. 2023. 68-79. DOI: 10.1016/j.trsl.2022.08.016. IF: 7,8 Q1 D2
Castillo-González J, Ruiz JL, Serrano-Martinez I, Forte-Lago I, Ubago-Rodriguez A, Caro M, Pérez-Gómez JM, Benitez-Troncoso A, Andrés-León E, Sánchez-Navarro M, Luque RM, González-Rey E. Cortistatin deficiency reveals a dysfunctional brain endothelium with impaired gene pathways, exacerbated immune activation, and disrupted barrier integrity. JOURNAL OF NEUROINFLAMMATION. 2023. DOI: 10.1186/s12974-023-02908-5. IF: 9,3 Q1 D1
Diez-Cirarda M, Yus-Fuertes M, Sanchez-Sanchez R, Gonzalez-Rosa JJ, Gonzalez-Escamilla G, Gil-Martinez L, Delgado-Alonso C, Gil-Moreno MJ, Valles-Salgado M, Cano-Cano F, Ojeda-Hernandez D, Gomez-Ruiz N, Oliver-Mas S, Benito-Martin MS, Jorquera M, de la Fuente S, Polidura C, Selma-Calvo B, Arrazola J, Matias-Guiu J, Gomez-Pinedo U, Matias-Guiu JA. Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome. EBIOMEDICINE. 2023. DOI: 10.1016/j.ebiom.2023.104711. IF: 11,1 Q1 D1
Modena D, Moras ML, Sandrone G, Stevenazzi A, Vergani B, Dasgupta P, Kliever A, Gulde S, Marangelo A, Schillmaier M, Luque RM, Bauerle S, Pellegata NS, Schulz S, Steinkuhler C. Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas. CANCERS. 2023. DOI: 10.3390/cancers15133453. IF: 5,2 Q2 D3
Iglesias S, Munarriz PM, Saceda J, Catalan-Uribarrena G, Miranda P, Vidal JM, Fustero D, Gimenez-Pando J, Rius F. Multicentric and collaborative study of Spanish neurosurgical management of pediatric craniopharyngiomas: S-PedCPG.co. NEUROCIRUGIA. 2023. 67-74. DOI: 10.1016/j.neucir.2022.01.003. IF: 0,8 Q4 D
Vargas-Rodríguez P, Cuenca-Martagón A, Castillo-González J, Serrano-Martínez I, Luque RM, Delgado M, González-Rey E. Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023. DOI: 10.3390/ijms241814117. IF: 5,6 Q1 D3
Publications in 2022
Alcala-Diaz JF, Larriva AADP, Torres-Pena JD, Rodriguez-Cantalejo F, Rangel-Zuniga OA, Yubero-Serrano EM, Gutierrez-Mariscal FM, Cardelo MP, Luque RM, Ordovas JM, Perez-Martinez P, Delgado-Lista J, Lopez-Miranda J. FRONTIERS IN NUTRITION. 2022. DOI: 10.3389/fnut.2022.885256
Vals-Delgado C, Alcala-Diaz JF, Molina-Abril H, Roncero-Ramos I, Caspers MPM, Schuren FHJ, Van den Broek TJ, Luque R, Perez-Martinez P, Katsiki N, Delgado-Lista J, Ordovas JM, van Ommen B, Camargo A, Lopez-Miranda J. JOURNAL OF ADVANCED RESEARCH. 2022. DOI: 10.1016/j.jare.2021.05.001
Romero-Cabrera JL, Garaulet M, Jimenez-Torres J, Alcala-Diaz JF, Navarro GMQ, Martin-Piedra L, Torres-Pena JD, Rodriguez-Cantalejo F, Rangel-Zuniga OA, Yubero-Serrano EM, Luque RM, Ordovas JM, Lopez-Miranda J, Perez-Martinez P, Garcia-Rios A. TRANSLATIONAL RESEARCH. 2022. DOI: 10.1016/j.trsl.2021.11.001
Dean A, Heredero-Jung S, Solivera J, Sanjuan A, Alamillos-Granados FJ. LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY. 2022. DOI: 10.1002/lio2.786
Lozano RC, Martinez CH, Delgado FJB. MEDICINA-LITHUANIA. 2022. DOI: 10.3390/medicina58121743
Gonzalez-Borja I, Viudez A, Alors-Perez E, Goni S, Amat I, Ghanem I, Pazo-Cid R, Feliu J, Alonso L, Lopez C, Arrazubi V, Gallego J, Perez-Sanz J, Hernandez-Garcia I, Vera R, Castano JP, Fernandez-Irigoyen J. CANCERS. 2022. DOI: 10.3390/cancers14235993
Cardelo MP, Alcala-Diaz JF, Gutierrez-Mariscal FM, Lopez-Moreno J, Villasanta-Gonzalez A, Arenas-de Larriva AP, De la Cruz-Ares S, Delgado-Lista J, Rodriguez-Cantalejo F, Luque RM, Ordovas JM, Perez-Martinez P, Camargo A, Lopez-Miranda J. MOLECULAR NUTRITION & FOOD RESEARCH. 2022. DOI: 10.1002/mnfr.202100652
Pellegrinelli V, Rodriguez-Cuenca S, Rouault C, Figueroa-Juarez E, Schilbert H, Virtue S, Moreno-Navarrete JM, Bidault G, Vazquez-Borrego MC, Dias AR, Pucker B, Dale M, Campbell M, Carobbio S, Lin YH, Vacca M, Aron-Wisnewsky J, Mora S, Masiero MM, Emmanouilidou A, Mukhopadhyay S, Dougan G, den Hoed M, Loos RJF, Fernandez-Real JM, Chiarugi D, Clement K, Vidal-Puig A. NATURE METABOLISM. 2022. DOI: 10.1038/s42255-022-00561-5
Gahete MD, Herman-Sanchez N, Fuentes-Fayos AC, Lopez-Canovas JL, Luque RM. ENDOCRINE-RELATED CANCER. 2022. DOI: 10.1530/ERC-22-0019
Herrero-Aguayo V, Saez-Martinez P, Jimenez-Vacas JM, Moreno-Montilla MT, Montero-Hidalgo AJ, Perez-Gomez JM, Lopez-Canovas JL, Porcel-Pastrana F, Carrasco-Valiente J, Anglada FJ, Gomez-Gomez E, Yubero-Serrano EM, Ibanez-Costa A, Herrera-Martinez AD, Sarmento-Cabral A, Gahete MD, Luque RM. MOLECULAR THERAPY-NUCLEIC ACIDS. 2022. DOI: 10.1016/j.omtn.2022.02.010
Pedraza-Arevalo S, Ibanez-Costa A, Blazquez-Encinas R, Branco MR, Vazquez-Borrego MC, Herrera-Martinez AD, Venegas-Moreno E, Serrano-Blanch R, Arjona-Sanchez A, Galvez-Moreno MA, Korbonits M, Soto-Moreno A, Gahete MD, Charalambous M, Luque RM, Castano JP. MOLECULAR ONCOLOGY. 2022. DOI: 10.1002/1878-0261.13107
Barragan-Prieto A, Perez-Sanchez S, Moniche F, Moyano RV, Delgado F, Martinez-Sanchez P, Moya M, Oropesa JM, Minguez-Castellanos A, Villegas I, Soria MJA, Toledo JAT, Cosme CD, Neguillo RC, Esteban JMH, Cobos DJM, Munoz JAM, Gonzalez A, Montaner J. EUROPEAN STROKE JOURNAL. 2022. DOI: 10.1177/23969873221101282
Giraldez-Perez RM, Grueso E, Montero-Hidalgo AJ, Luque RM, Carnerero JM, Kuliszewska E, Prado-Gotor R. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022. DOI: 10.3390/ijms232415575
Moon JS, Riopel M, Seo JB, Herrero-Aguayo V, Isaac R, Lee YS. DIABETES. 2022. DOI: 10.2337/db21-0736
de la Cruz-Ares S, Leon-Acuna A, Yubero-Serrano EM, Torres-Pena JD, Larriva APAD, Cardelo MP, Rangel-Zuniga OA, Luque RM, Alcala-Diaz JF, Ordovas JM, Perez-Martinez P, Lopez-Miranda J, Delgado-Lista J. CLINICA CHIMICA ACTA. 2022. DOI: 10.1016/j.cca.2022.06.002
Montoro LC, Ortiz MR, Hurtado NP, Ortega MD, Almodovar AR, Saint-Gerons JMS, Bellido FM, Sepulveda JJO, Moyano RV, Moreno MAR, Alvarez-Ossorio MP, Rubio MDM. NEUROLOGICAL SCIENCES. 2022. DOI: 10.1007/s10072-021-05524-4
Herrera-Martinez AD, Herrero-Aguayo V, Perez-Gomez JM, Gahete MD, Luque RM. OBESITY. 2022. DOI: 10.1002/oby.23581
Moreno-Moreno P, Ibanez-Costa A, Venegas-Moreno E, Fuentes-Fayos AC, Alhambra-Exposito MR, Fajardo-Montanana C, Garcia-Martinez A, Dios E, Vazquez-Borrego MC, Remon-Ruiz P, Camara R, Lamas C, Padillo-Cuenca JC, Solivera J, Cano DA, Gahete MD, Herrera-Martinez AD, Pico A, Soto-Moreno A, Galvez-Moreno MA, Castano JP, Luque RM. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022. DOI: 10.1210/clinem/dgac172
Acosta FD, Rey IB, Gomez EJ, Saucedo VR, Toledano A, Fernandez RO. ACTA NEUROLOGICA SCANDINAVICA. 2022. DOI: 10.1111/ane.13686
Podadera-Herreros A, Alcala-Diaz JF, Gutierrez-Mariscal FM, Jimenez-Torres J, De La Cruz-Ares S, Arenas-de Larriva AP, Cardelo MP, Torres-Pena JD, Luque RM, Ordovas JM, Delgado-Lista J, Lopez-Miranda J, Yubero-Serrano EM. CLINICAL NUTRITION. 2022. DOI: 10.1016/j.clnu.2021.12.041
Jurado-Castro JM, Campos-Perez J, Vilches-Redondo MA, Mata F, Navarrete-Perez A, Ranchal-Sanchez A. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2022. DOI: 10.3390/ijerph19010393
Leon-Idougourram S, Perez-Gomez JM, Jimenez CM, L-Lopez F, Garcia GM, Puertas MJM, Herman-Sanchez N, Alonso-Echague R, Continente AC, Moreno MAG, Luque RM, Gahete MD, Herrera-Martinez AD. CANCERS. 2022. DOI: 10.3390/cancers14030494
Amaro-Gahete FJ, Jurado J, Cisneros A, Corres P, Marmol-Perez A, Osuna-Prieto FJ, Fernandez-Escabias M, Salcedo E, Herman-Sanchez N, Gahete MD, Aparicio VA, Gonzalez-Callejas C, Pozo BM, Ruiz JR, Nestares T, Carneiro-Barrera A. NUTRIENTS. 2022. DOI: 10.3390/nu14214647
Herrera-Martinez Y, Teomiro CA, Idougourram SL, Puertas MJM, Continente AC, Blanch RS, Castano JP, Moreno MAG, Gahete MD, Luque RM, Herrera-Martinez AD. CANCERS. 2022. DOI: 10.3390/cancers14010111
Fuentes-Fayos AC, Perez-Gomez JM, G-Garcia ME, Jimenez-Vacas JM, Blanco-Acevedo C, Sanchez-Sanchez R, Solivera J, Breunig JJ, Gahete MD, Castano JP, Luque RM. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2022. DOI: 10.1186/s13046-022-02241-4
Fuentes-Fayos AC, G-Garcia ME, Perez-Gomez JM, Peel A, Blanco-Acevedo C, Solivera J, Ibanez-Costa A, Gahete MD, Castano JP, Luque RM. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022. DOI: 10.3390/ijms23031143
Saez-Martinez P, Porcel-Pastrana F, Perez-Gomez JM, Pedraza-Arevalo S, Gomez-Gomez E, Jimenez-Vacas JM, Gahete MD, Luque RM. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022. DOI: 10.3390/ijms232113003
Lopez-Canovas JL, Herman-Sanchez N, Moreno-Montilla MT, Del Rio-Moreno M, Alors-Perez E, Sanchez-Frias ME, Amado V, Ciria R, Briceno J, de la Mata M, Castano JP, Rodriguez-Peralvarez M, Luque RM, Gahete MD. CLINICAL AND TRANSLATIONAL MEDICINE. 2022. DOI: 10.1002/ctm2.1102
Ibanez-Costa A, Perez-Sanchez C, Patino-Trives AM, Luque-Tevar M, Font P, de la Rosa IA, Roman-Rodriguez C, Abalos-Aguilera MC, Conde C, Gonzalez A, Pedraza-Arevalo S, del Rio-Moreno M, Blazquez-Encinas R, Segui P, Calvo J, Castro RO, Escudero-Contreras A, Barbarroja N, Aguirre MA, Castano-Fuentes JP, Luque RM, Collantes-Estevez E, Lopez-Pedrera C. ANNALS OF THE RHEUMATIC DISEASES. 2022. DOI: 10.1136/annrheumdis-2021-220308
Leon-Gonzalez AJ, Navarro I, Acero N, Munoz-Mingarro D, Martin-Cordero C. PHYTOCHEMISTRY REVIEWS. 2022. DOI: 10.1007/s11101-021-09787-9
Publications in 2021
Jimenez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, Saez-Martinez P, Gomez-Gomez E, Leon-Gonzalez AJ, Fuentes-Fayos AC, Yubero-Serrano EM, Requena-Tapia MJ, Lopez M, Castano JP, Gahete MD, Luque RM. Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 202 106(2):E696-E710. DOI: 10.1210/clinem/dgaa877.
IF: 5,958 Q1 D2
Leon-Gonzalez AJ, Saez-Martinez P, Jimenez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, Gomez-Gomez E, Madrona A, Castano JP, Espartero JL, Gahete MD, Luque RM. Comparative Cytotoxic Activity of Hydroxytyrosol and Its Semisynthetic Lipophilic Derivatives in Prostate Cancer Cells. ANTIOXIDANTS. 2021. 10(9):-. DOI: 10.3390/antiox10091348.
IF: 6,312 Q1 D1
Heredero S, Falguera-Uceda MI, Sanjuan-Sanjuan A, Dean A, Solivera J. Chimeric profunda artery perforator - gracilis flap: A computed tomographic angiography study and case report. MICROSURGERY. 2021. 41(3):250-257. DOI: 10.1002/micr.30694. IF: 2,425 Q2 D5
Alors-Perez E, Blazquez-Encinas R, Alcala S, Viyuela-Garcia C, Pedraza-Arevalo S, Herrero-Aguayo V, Jimenez-Vacas JM, Mafficini A, Sanchez-Frias ME, Cano MT, Abollo-Jimenez F, Marin-Sanz JA, Cabezas-Sainz P, Lawlor RT, Luchini C, Sanchez L, Sanchez-Hidalgo JM, Ventura S, Martin-Hijano L, Gahete MD, Scarpa A, Arjona-Sanchez A, Ibanez-Costa A, Sainz B, Luque RM, Castano JP. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2021. 40(1):-. DOI: 10.1186/s13046-021-02153-9.
IF: 11,161 Q1 D1
Herrero-Aguayo V, Saez-Martinez P, Lopez-Canovas JL, Prados-Carmona JJ, Alcantara-Laguna MD, Lopez FL, Molina-Puerta MJ, Calanas-Continente A, Membrives A, Castilla J, Ruiz-Ravelo J, Alonso-Echague R, Yubero-Serrano EM, Castano JP, Gahete MD, Galvez-Moreno MA, Luque RM, Herrera-Martinez AD. Dysregulation of Components of the Inflammasome Machinery After Bariatric Surgery: Novel Targets for a Chronic Disease. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2021. 106(12):E4917-E4934. DOI: 10.1210/clinem/dgab586.
IF: 5,958 Q1 D2
Jimenez-Vacas JM, Montero-Hidalgo AJ, Gomez-Gomez E, Fuentes-Fayos AC, Ruiz-Pino F, Guler I, Camargo A, Anglada FJ, Carrasco-Valiente J, Tena-Sempere M, Sarmento-Cabral A, Castano JP, Gahete MD, Luque RM. In 1-Ghrelin Splicing Variant as a Key Element in the Pathophysiological Association Between Obesity and Prostate Cancer. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2021. 106(12):E4956-E4968. DOI: 10.1210/clinem/dgab51
IF: 5,958 Q1 D2
Herrero-Aguayo V, Jimenez-Vacas JM, Saez-Martinez P, Gomez-Gomez E, Lopez-Canovas JL, Garrido-Sanchez L, Herrera-Martinez AD, Garcia-Bermejo L, Macias-Gonzalez M, Lopez-Miranda J, Castano JP, Gahete MD, Luque RM. Influence of Obesity in the miRNome: miR-4454, a Key Regulator of Insulin Response Via Splicing Modulation in Prostate. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2021. 106(2):E469-E484. DOI: 10.1210/clinem/dgaa580.
IF: 5,958 Q1 D2
Sanjuan-Sanjuan A, Alors-Perez E, Sanchez-Frias M, Dean-Ferrer A, Gahete MD, Heredero-Jung S, Luque RM. Molecular and Clinical Implications of Somatostatin Receptor Profile and Somatostatin Analogues Treatment in Oral Cavity Squamous Cell Carcinoma. CANCERS. 2021. 13(19):-. DOI: 10.3390/cancers1319482
IF: 6,639 Q1 D2
Leon-Gonzalez AJ, Jimenez-Vacas JM, Fuentes-Fayos AC, Sarmento-Cabral A, Herrera-Martinez AD, Gahete MD, Luque RM. Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers. CURRENT OPINION IN PHARMACOLOGY. 2021. 60():17-26. DOI: 10.1016/j.coph.2021.06.002.
IF: 5,547 Q1 D2
Lopez-Canovas JL, del Rio-Moreno M, Garcia-Fernandez H, Jimenez-Vacas JM, Moreno-Montilla MT, Sanchez-Frias ME, Amado V, Lopez FL, Fondevila MF, Ciria R, Gomez-Luque I, Briceno J, Nogueiras R, de la Mata M, Castano JP, Rodriguez-Peralvarez M, Luque RM, Gahete MD. Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma. CANCER LETTERS. 2021. 496():72-83. DOI: 1016/j.canlet.2020.10.010.
IF: 8,679 Q1 D2
Rangel-Zuniga OA, Vals-Delgado C, Alcala-Diaz JF, Quintana-Navarro GM, Krylova Y, Leon-Acuna A, Luque RM, Gomez-Delgado F, Delgado-Lista J, Ordovas JM, Perez-Martinez P, Camargo A, Lopez-Miranda J. A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study. MOLECULAR THERAPY-NUCLEIC ACIDS. 202 23():255-263. DOI: 10.1016/j.omtn.2020.1001. IF: 8,886 Q1 D1
Roncero-Ramos I, Gutierrez-Mariscal FM, Gomez-Delgado F, Villasanta-Gonzalez A, Torres-Pena JD, de la Cruz-ares S, Rangel-Zuniga OA, Luque RM, Ordovas JM, Delgado-Lista J, Perez-Martinez P, Camargo A, Alcala-Diaz JF, Lopez-Miranda J. Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial. TRANSLATIONAL RESEARCH. 2021. 238():12-24. DOI: 10.1016/j.trsl.2021.07.001.
IF: 7,012 Q1 D1
Martin-Piedra L, Alcala-Diaz JF, Gutierrez-Mariscal FM, de Larriva AAP, Romero-Cabrera JL, Torres-Pena JD, Caballero-Villarraso J, Luque RM, Perez-Martinez P, Lopez-Miranda J, Delgado-Lista J. Evolution of Metabolic Phenotypes of Obesity in Coronary Patients after 5 Years of Dietary Intervention: From the CORDIOPREV Study. NUTRIENTS. 2021. 13(11):-. DOI: 10.3390/nu13114046.
IF: 5,719 Q1 D2
Sanchez-Ceinos J, Guzman-Ruiz R, Rangel-Zuniga OA, Lopez-Alcala J, Moreno-Cano E, Del Rio-Moreno M, Romero-Cabrera JL, Perez-Martinez P, Maymo-Masip E, Vendrell J, Fernandez-Veledo S, Fernandez-Real JM, Laurencikiene J, Ryden M, Membrives A, Luque RM, Lopez-Miranda J, Malagon MM. Impaired mRNA splicing and proteostasis in preadipocytes in obesity-related metabolic disease. ELIFE. 2021. 10():-. DOI: 10.7554/eLife.65996; 10.7554/eLife.65996.sa1; 10.7554/eLife.65996.sa2.
IF: 8,14 Q1 D1
Jimenez-Lucena R, Alcala-Diaz JF, Roncero-Ramos I, Lopez-Moreno J, Camargo A, Gomez-Delgado F, Quintana-Navarro GM, Vals-Delgado C, Rodriguez-Cantalejo F, Luque RM, Delgado-Lista J, Ordovas JM, Perez-Martinez P, Rangel-Zuniga OA, Lopez-Miranda J. MiRNAs profile as biomarkers of nutritional therapy for the prevention of type 2 diabetes mellitus: From the CORDIOPREV study. CLINICAL NUTRITION. 2021. 40(3):1028-1038. DOI: 10.1016/j.clnu.2020.06.03
IF: 7,324 Q1 D1
Lendinez-Cano G, Ojeda-Claro AV, Gomez-Gomez E, Jimenez PM, Martin JF, Dominguez JF, Amores J, Cozar JM, Bachiller J, Juarez A, Linares R, Galisteo EG, Ossorio JLA, Tapia MJR, Jimenez JM, Lopez RAM. Prospective study of diagnostic accuracy in the detection of high-grade prostate cancer in biopsy-naive patients with clinical suspicion of prostate cancer who underwent the Select MDx test. PROSTATE. 2021. 81(12):857-865. DOI: 10.1002/pros.24182.
IF: 4,104 Q2 D3
Gutierrez-Mariscal FM, Cardelo MP, de la Cruz S, Alcala-Diaz JF, Roncero-Ramos I, Guler I, Vals-Delgado C, Lopez-Moreno A, Luque RM, Delgado-Lista J, Perez-Martinez P, Yubero-Serrano EM, Lopez-Miranda J. Reduction in Circulating Advanced Glycation End Products by Mediterranean Diet Is Associated with Increased Likelihood of Type 2 Diabetes Remission in Patients with Coronary Heart Disease: From the Cordioprev Study. MOLECULAR NUTRITION & FOOD RESEARCH. 2021. 65(1):-. DOI: 10.1002/mnfr.201901290.
IF: 5,914 Q1 D2
Millan-Orge M, Torres-Pena JD, Arenas-Larriva A, Quintana-Navarro GM, Pena-Orihuela P, Alcala-Diaz JF, Luque RM, Rodriguez-Cantalejo F, Katsiki N, Lopez-Miranda J, Perez-Martinez P, Delgado-Lista J. Influence of dietary intervention on microvascular endothelial function in coronary patients and atherothrombotic risk of recurrence. SCIENTIFIC REPORTS. 2021. 11(1):-. DOI: 10.1038/s41598-021-99514-3.
IF: 4,38 Q1 D3
Gesmundo I, Pardini B, Gargantini E, Gamba G, Birolo G, Fanciulli A, Banfi D, Congiusta N, Favaro E, Deregibus MC, Togliatto G, Zocaro G, Brizzi MF, Luque RM, Castano JP, Bocchiotti MA, Arolfo S, Bruno S, Nano R, Morino M, Piemonti L, Ong H, Matullo G, Falcon-Perez JM, Ghigo E, Camussi G, Granata R. Adipocyte-derived extracellular vesicles regulate survival and function of pancreatic beta cells. JCI INSIGHT. 2021. 6(5):-. DOI: 10.1172/jci.insight.141962.
IF: 8,315 Q1 D2
Gesmundo I, Granato G, Fuentes-Fayos AC, Alvarez CV, Dieguez C, Zatelli MC, Congiusta N, Banfi D, Prencipe N, Leone S, Brunetti L, Castano JP, Luque RM, Cai RZ, Sha W, Ghigo E, Schally AV, Granata R. Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic Signaling. CANCERS. 2021. 13(16):-. DOI: 3390/cancers13163950.
IF: 6,639 Q1 D3
Mirabelli M, Chiefari E, Tocci V, Caroleo P, Giuliano S, Greco E, Luque RM, Puccio L, Foti DP, Aversa A, Brunetti A. Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes. JOURNAL OF CLINICAL MEDICINE. 2021. 10(5):-. DOI: 10.3390/jcm10050985.
IF: 4,241 Q1 D3
Gonzalez-Borja I, Alors-Perez E, Amat I, Alonso L, Viyuela-Garcia C, Goni S, Reyes JC, Ceballos-Chavez M, Hernandez-Garcia I, Sanchez-Frias ME, Santamaria E, Razquin S, Arjona-Sanchez A, Arrazubi V, Perez-Sanz J, Vera R, Fernandez-Irigoyen J, Castano JP, Viudez A. Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma. FRONTIERS IN MEDICINE. 2021. 8():-. DOI: 10.3389/fmed.2021.720128.
IF: 5,093 Q1 D2
Sanchez-Hidalgo M, Leon-Gonzalez AJ, Galvez-Peralta M, Gonzalez-Mauraza NH, Martin-Cordero C. d-Pinitol: a cyclitol with versatile biological and pharmacological activities. PHYTOCHEMISTRY REVIEWS. 2021. 20(1):211-224. DOI: 10.1007/s11101-020-09677-6.
IF: 5,374 Q1 D1
Gulde S, Wiedemann T, Schillmaier M, Valenca I, Lupp A, Steiger K, Yen HY, Bauerle S, Notni J, Luque R, Schmid H, Schulz S, Ankerst DP, Schilling F, Pellegata NS. Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors. CANCERS. 2021. 13(12):-. DOI: 10.3390/cancers13123097.
IF: 6,639 Q1 D3
Lamback EB, Henriques DG, Vazquez-Borrego MC, Lima CHD, Kasuki L, Luque RM, Chimelli L, Gadelha MR. Growth hormone-releasing hormone-secreting pulmonary neuroendocrine tumor associated with pituitary hyperplasia and somatotropinoma. ARCHIVES OF ENDOCRINOLOGY METABOLISM. 2021. 65(5):648-663. DOI: 10.20945/2359-3997000000395.
IF: 2,309 Q4
Paschalis A, Welti J, Neeb AJ, Yuan W, Figueiredo I, Pereira R, Ferreira A, Riisnaes R, Rodrigues DN, Jimenez-Vacas JM, Kim S, Uo T, Di Micco P, Tumber A, Islam MS, Moesser MA, Abboud M, Kawamura A, Gurel B, Christova R, Gil VS, Buroni L, Crespo M, Miranda S, Lambros MB, Carreira S, Tunariu N, Alimonti A, Al-Lazikani B, Schofield CJ, Plymate SR, Sharp A, de Bono JS. JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer. CANCER RESEARCH. 2021. 81(4):1087-1100. DOI: 10.1158/0008-5472.CAN-20-1807.
IF: 12,701 Q1 D1
Pico A, Aranda-Lopez I, Sesmilo G, Toldos-Gonzalez O, Japon MA, Luque RM, Puig-Domingo M. Recommendations on the pathological report of pituitary tumors. A consensus of experts of the Spanish Society of Endocrinology and Nutrition and the Spanish Society of Pathology. ENDOCRINOLOGIA DIABETES Y NUTRICION. 2021. 68(3):196-207. DOI: 10.1016/j.endinu.2020.10.004.
IF: 1,417 Q4
homas PB, Jeffery P, Gahete MD, Whiteside E, Walpole C, Maugham M, Jovanovic L, Gunter J, Williams E, Nelson C, Herington A, Luque RM, Veedu R, Chopin LK, Seim I. The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype. PEERJ. 202 9():-. DOI: 10.7717/peerj.10280.
IF: 2,984 Q2 D4
Publications in 2020
Vazquez-Borrego MC, L-Lopez F, Galvez-Moreno MA, Fuentes-Fayos AC, Venegas-Moreno E, Herrera-Martinez AD, Blanco-Acevedo C, Solivera J, Landsman T, Gahete MD, Soto-Moreno A, Culler MD, Castano JP, Luque RM. A New Generation Somatostatin-Dopamine Analogue Exerts Potent Antitumoral Actions on Pituitary Neuroendocrine Tumor Cells. NEUROENDOCRINOLOGY. 2020. 110 (1-2):70-82 DOI: 10.1159/000500812
IF: 4,271 Q: 1
Lopez-Andreu M, Cabello MDN, Sanchez-Sanchez R, Rodriguez-Portillo JM, Cabrera SS. A patient with recurrent ventricular fibrillation and renal failure. KIDNEY INTERNATIONAL. 2020. 98 (3):795-796 DOI: 10.1016/j.kint.2020.03.013
IF: 8,945 Q: 1 D: 1
Segura JS, Rosa JV, Gomez EG, Cabello MDN, Garcia JR, Benot AR, Garcia JER, Tapia MJR, Hernandez JPC. A Single-Center Experience With Third and Fourth Kidney Transplants and Second Kidney Transplant After Pancreas-Kidney Transplant Surgical Aspects and Outcomes. EXPERIMENTAL AND CLINICAL TRANSPLANTATION. 2020. 18 (2):149-152 DOI: 10.6002/ect.2019.0372
IF: 0,852 Q: 4
Vazquez-Borrego MC, Gupta V, Ibanez-Costa A, Gahete MD, Venegas-Moreno E, Toledano-Delgado A, Cano DA, Blanco-Acevedo C, Ortega-Salas R, Japon MA, Barrera-Martin A, Vasiljevic A, Hill J, Zhang SW, Halem H, Solivera J, Raverot G, Galvez MA, Soto-Moreno A, . A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors. CLINICAL CANCER RESEARCH. 2020. 26 (4):957-969 DOI: 10.1158/1078-0432.CCR-19-2154
IF: 10,107 Q: 1
Reyes O, Perez E, Luque RM, Castano J, Ventura S. A supervised machine learning-based methodology for analyzing dysregulation in splicing machinery: An application in cancer diagnosis. ARTIFICIAL INTELLIGENCE IN MEDICINE. 2020. 108 ():- DOI: 10.1016/j.artmed.2020.101950
IF: 4,383 Q: 1
Gutierrez-Mariscal FM, Garcia-Rios A, Gomez-Luna P, Fernandez-Gandara C, Cardelo MP, de la Cruz-Ares S, Rodriguez-Cantalejo F, Luque RM, Leon-Acuna A, Delgado-Lista J, Perez-Martinez P, Yubero-Serrano EM, Lopez-Miranda J. Age-dependent effect of metabolic phenotypes on carotid atherosclerotic disease in coronary heart disease patients (CORDIOPREV study). BMC GERIATRICS. 2020. 20 (1):- DOI: 10.1186/s12877-020-01544-5
IF: 3,077 Q: 1
Gatto F, Perez-Rivas LG, Olarescu NC, Khandeva P, Chachlaki K, Trivellin G, Gahete MD, Cuny T. Diagnosis and Treatment of Parasellar Lesions. NEUROENDOCRINOLOGY. 2020. 110 (44113):728-739 DOI: 10.1159/000506905
IF: 4,271 Q: 1
del Rio-Moreno M, Luque RM, Rangel-Zuniga OA, Alors-Perez E, Alcala-Diaz JF, Roncero-Ramos I, Camargo A, Gahete MD, Lopez-Miranda J, Castano JP. Dietary Intervention Modulates the Expression of Splicing Machinery in Cardiovascular Patients at High Risk of Type 2 Diabetes Development: From the CORDIOPREV Study. NUTRIENTS. 2020. 12 (11):- DOI: 10.3390/nu12113528
IF: 4,546 Q: 1
Garcia-Martinez A, Fuentes-Fayos AC, Fajardo C, Lamas C, Camara R, Lopez-Munoz B, Aranda I, Luque RM, Pico A. Differential Expression of MicroRNAs in Silent and Functioning Corticotroph Tumors. JOURNAL OF CLINICAL MEDICINE. 2020. 9 (6):- DOI: 10.3390/jcm9061838
IF: 3,303 Q: 1
Jimenez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, Gomez-Gomez E, Fuentes-Fayos AC, Leon-Gonzalez AJ, Saez-Martinez P, Alors-Perez E, Pedraza-Arevalo S, Gonzalez-Serrano T, Reyes O, Martinez-Lopez A, Sanchez-Sanchez R, Ventura S, Yubero-Serrano EM, R. Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBIOMEDICINE. 2020. 51 ():- DOI: 10.1016/j.ebiom.2019.11.008
IF: 5,736 Q: 1
Sanchez-Garrido MA, Ruiz-Pino F, Pozo-Salas AI, Castellano JM, Vazquez MJ, Luque RM, Tena-Sempere M. Early overnutrition sensitizes the growth hormone axis to the impact of diet-induced obesity via sex-divergent mechanisms. SCIENTIFIC REPORTS. 2020. 10 (1):- DOI: 10.1038/s41598-020-70898-y
IF: 3,998 Q: 1
Puche-Sanz I, Sabio-Bonilla A, Sanchez-Conde V, Jimenez-Dominguez AC, Tamayo-Gomez A, Vila-Brana P, Vazquez-Alonso F, Rivas JG, Gomez-Gomez E, Campos-Juanatey F, Rodriguez JGO, Flores-Martin J, Moreno-Jimenez J, Cozar-Olmo JM. Emergency surgery during COVID-19 pandemia. ARCHIVOS ESPANOLES DE UROLOGIA. 2020. 73 (5):353-359
IF: 0,395 Q: 4
Quintana-Navarro GM, Alcala-Diaz JF, Lopez-Moreno J, Perez-Corral I, Leon-Acuna A, Torres-Pena JD, Rangel-Zuniga OA, de Larriva APA, Corina A, Camargo A, Yubero-Serrano EM, Rodriguez-Cantalejo F, Garcia-Rios A, Luque RM, Ordovas JM, Perez-Martinez P, Lope. Long-term dietary adherence and changes in dietary intake in coronary patients after intervention with a Mediterranean diet or a low-fat diet: the CORDIOPREV randomized trial. EUROPEAN JOURNAL OF NUTRITION. 2020. 59 (5):2099-2110 DOI: 10.1007/s00394-019-02059-5
IF: 4,664 Q: 1
Pozuelo-Sanchez I, Villasanta-Gonzalez A, Alcala-Diaz JF, Vals-Delgado C, Leon-Acuna A, Gonzalez-Requero A, Yubero-Serrano EM, Luque RM, Caballero-Villarraso J, Quesada I, Ordovas JM, Perez-Martinez P, Roncero-Ramos I, Lopez-Miranda J. Postprandial Lipemia Modulates Pancreatic Alpha-Cell Function in the Prediction of Type 2 Diabetes Development: The CORDIOPREV Study. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY. 2020. 68 (5):1266-1275 DOI: 10.1021/acs.jafc.9b06801
IF: 4,192 Q: 1 D: 1
Roncero-Ramos I, Alcala-Diaz JF, Rangel-Zuniga OA, Gomez-Delgado F, Jimenez-Lucena R, Garcia-Rios A, Vals-Delgado C, Romero-Baldonado C, Luque RM, Ordovas JM, Perez-Martinez P, Camargo A, Lopez-Miranda J. Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study. CLINICAL NUTRITION. 2020. 39 (2):492-500 DOI: 10.1016/j.clnu.2019.02.027
IF: 6,36 Q: 1
Flores-Martinez A, Venegas-Moreno E, Dios E, Remon-Ruiz P, Gros-Herguido N, Vazquez-Borrego MC, Madrazo-Atutxa A, Japon MA, Kaen A, Cardenas-Valdepenas E, Roldan F, Castano JP, Luque RM, Cano DA, Soto-Moreno A. Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features. JOURNAL OF CLINICAL MEDICINE. 2020. 9 (9):- DOI: 10.3390/jcm9093052
IF: 3,303 Q: 1
Gutierrez-Mariscal FM, Cardelo MP, de la Cruz S, Alcala-Diaz JF, Roncero-Ramos I, Guler I, Vals-Delgado C, Lopez-Moreno A, Luque RM, Delgado-Lista J, Perez-Martinez P, Yubero-Serrano EM, Lopez-Miranda J. Reduction in Circulating Advanced Glycation End Products by Mediterranean Diet Is Associated with Increased Likelihood of Type 2 Diabetes Remission in Patients with Coronary Heart Disease: From the Cordioprev Study. MOLECULAR NUTRITION & FOOD RESEARCH. 2021. 65 (1):- DOI: 10.1002/mnfr.201901290
IF: 5,309 Q: 1 D: 1
Fuentes-Fayos AC, Vazquez-Borrego MC, Jimenez-Vacas JM, Bejarano L, Pedraza-Arevalo S, L-Lopez F, Blanco-Acevedo C, Sanchez-Sanchez R, Reyes O, Ventura S, Solivera J, Breunig JJ, Blasco MA, Gahete MD, Castano JP, Luque RM. Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3. BRAIN. 2020. 143 ():3273-3293 DOI: 10.1093/brain/awaa273
IF: 11,337 Q: 1 D: 1
Vazquez-Borrego MC, Fuentes-Fayos AC, Herrera-Martinez AD, Venegas-Moreno E, L-Lopez F, Fanciulli A, Moreno-Moreno P, Alhambra-Exposito MR, Barrera-Martin A, Dios E, Blanco-Acevedo C, Solivera J, Granata R, Kineman RD, Gahete MD, Soto-Moreno A, Galvez-Moreno MA, Castano JP, Luque RM. Statins Directly Regulate Pituitary Cell Function and Exert Antitumor Effects in Pituitary Tumors. NEUROENDOCRINOLOGY. 2020. 110 (44176):1028-1041 DOI: 10.1159/000505923
IF: 4,271 Q: 1
Saez-Martinez P, Jimenez-Vacas JM, Leon-Gonzalez AJ, Herrero-Aguayo V, Hidalgo AJM, Gomez-Gomez E, Sanchez-Sanchez R, Requena-Tapia MJ, Castano JP, Gahete MD, Luque RM. Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer. JOURNAL OF CLINICAL MEDICINE. 2020. 9 (6):- DOI: 10.3390/jcm9061703
IF: 3,303 Q: 1"
Publications in 2019
Jiménez-Vacas JM, Gómez-Gómez E, Montero-Hidalgo AJ, Herrero-Aguayo V, L-López F, Sánchez-Sánchez R, Guler I, Blanca A, Méndez-Vidal MJ, Carrasco J, Lopez-Miranda J, Requena-Tapia MJ, Castaño JP, Gahete MD, Luque RM. Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer. JOURNAL OF CLINICAL MEDICINE. 2019 Nov 22;8(12). pii: E2056. doi: 10.3390/jcm8122056.
IF: 5,583 Q: 1 D: 1
Del Rio-Moreno M, Alors-Perez E, De Souza PB, Prados-Gonzalez ME, Castano JP, Luque RM, Gahete MD; Peptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell types. TRANSLATIONAL RESEARCH. 2019 Sep;211:147-160. doi: 10.1016/j.trsl.2019.02.013.
IF: 4,915 Q: 1 D: 1
Jimenez-Vacas JM, Herrero-Aguayo V, Gomez-Gomez E, Leon-Gonzalez AJ, Saez-Martinez P, Alors-Perez E, Fuentes-Fayos AC, Martinez-Lopez A, Sanchez-Sanchez R, Gonzalez-Serrano T, Lopez-Ruiz DJ, Requena-Tapia MJ, Castano JP, Gahete MD, Luque RM; Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer. TRANSLATIONAL RESEARCH. 212. (89-103). DOI: 10.1016/j.trsl.2019.07.001.
IF: 4,915 Q: 1 D: 1
Vazquez-Borrego MC, Fuentes-Fayos AC, Venegas-Moreno E, Rivero-Cortes E, Dios E, Moreno-Moreno P, Madrazo-Atutxa A, Remon P, Solivera J, Wildemberg LE, Kasuki L, Lopez-Fernandez JM, Gadelha MR, Galvez-Moreno MA, Soto-Moreno A, Gahete MD, Castano JP, Luque RM; Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features. CANCERS. 2019 Sep 26;11(10). pii: E1439. doi: 10.3390/cancers11101439.
IF: 6,162 Q: 1
Gomez-Gomez, E; Jimenez-Vacas, JM; Pedraza-Arevalo, S; Lopez-Lopez, F; Herrero-Aguayo, V; Hormaechea-Agulla, D; Valero-Rosa, J; Ibanez-Costa, A; Leon-Gonzalez, AJ; Sanchez-Sanchez, R; Gonzalez-Serrano, T; Requena-Tapia, MJ; Castano, JP; Carrasco-Valiente, Gahete MD, Luque RM; Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer. JOURNAL OF CLINICAL MEDICINE. 2019 Sep 6;8(9). pii: E1400. doi: 10.3390/jcm8091400.
IF: 5,688 Q: 1 D: 1
Thomas PB, Seim I, Jeffery PL, Gahete MD, Maugham M, Crisp GJ, Stacey A, Shah ET, Walpole C, Whiteside EJ, Nelson CC, Herington AC, Luque RM, Veedu RN, Chopin LK. The long non-coding RNA GHSROS facilitates breast cancer cell migration and orthotopic xenograft tumour growth. INTERNATIONAL JOURNAL OF ONCOLOGY. 2019 Dec;55(6):1223-1236. doi: 10.3892/ijo.2019.4891.
IF: 3,571 D: 1
Quintana-Navarro GM, Alcala-Diaz JF, Lopez-Moreno J, Perez-Corral I, Leon-Acuña A, Torres-Peña JD, Rangel-Zuñiga OA, Arenas de Larriva AP, Corina A, Camargo A, Yubero-Serrano EM, Rodriguez-Cantalejo F, Garcia-Rios A, Luque RM, Ordovas JM, Perez-Martinez P, Lopez-Miranda J, Delgado-Lista J. Long-term dietary adherence and changes in dietary intake in coronary patients after intervention with a Mediterranean diet or a low-fat diet: the CORDIOPREV randomized trial. EUROPEAN JOURNAL OF NUTRITION. 2019 Jul 24. doi: 10.1007/s00394-019-02059-5.
IF: 4,449 D: 1
Hoa O, Lafont C, Fontanaud P, Guillou A, Kemkem Y, Kineman RD, Luque RM, Fiordelisio Coll T, Le Tissier P, Mollard P. Imaging and Manipulating Pituitary Function in the Awake Mouse. ENDOCRINOLOGY. 2019 Oct 1;160(10):2271-2281. doi: 10.1210/en.2019-00297.
IF: 3,800 D: 1
Herrera-Martínez AD, Pedraza-Arevalo S, L-López F, Gahete MD, Gálvez-Moreno MA, Castaño JP, Luque RM. Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?. THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2019 Jan 1;104(1):57-73. doi: 10.1210/jc.2018-01455.
Q: 1
Remacha L, Pirman D, Mahoney CE, Coloma J, Calsina B, Curras-Freixes M, Leton R, Torres-Perez R, Richter S, Pita G, Herraez B, Cianchetta G, Honrado E, Maestre L, Urioste M, Aller J, Garcia-Uriarte O, Galvez MA, Luque RM, Lahera M, Moreno-Rengel C, Eisenh; Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas. AMERICAN JOURNAL OF HUMAN GENETICS. 2019 Apr 4;104(4):651-664. doi: 10.1016/j.ajhg.2019.02.017
IF: 9,924 D: 1
Olarescu NC, Perez-Rivas LG, Gatto F, Cuny T, Tichomirowa MA, Tamagno G, Gahete MD; Aggressive and Malignant Prolactinomas. NEUROENDOCRINOLOGY. 2019;109(1):57-69. doi: 10.1159/000497205.
IF: 6,804 D: 1
Biagetti B, Herance JR, Ferrer R, Aulinas A, Palomino-Schatzlein M, Mesa J, Castano JP, Luque RM, Simo R; Metabolic Fingerprint of Acromegaly and Its Potential Usefulness in Clinical Practice. JOURNAL OF CLINICAL MEDICINE. 2019 Sep 26;8(10). pii: E1549. doi: 10.3390/jcm8101549.
IF: 5,688 Q:1 D:1
Vazquez-Borrego MC, Fuentes-Fayos AC, Herrera-Martinez AD, L-Lopez F, Ibanez-Costa A, Moreno-Moreno P, Alhambra-Exposito MR, Barrera-Martin A, Blanco-Acevedo C, Dios E, Venegas-Moreno E, Solivera J, Gahete MD, Soto-Moreno A, Galvez-Moreno MA, Castano JP, Luque RM; Biguanides Exert Antitumoral Actions in Pituitary Tumor Cells Through AMPK-Dependent and -Independent Mechanisms. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2019 Aug 1;104(8):3501-3513. doi: 10.1210/jc.2019-00056.
IF: 5,605 Q: 1
del Rio-Moreno M, Alors-Perez E, Gonzalez-Rubio S, Ferrin G, Reyes O, Rodriguez-Peralvarez M, Sanchez-Frias ME, Sanchez-Sanchez R, Ventura S, Lopez-Miranda J, Kineman RD, de la Mata M, Castano JP, Gahete MD, Luque RM; Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2019 Aug 1;104(8):3389-3402. doi: 10.1210/jc.2019-00021.
IF: 5,605 Q; 1
Herrera-Martinez AD, Hofland J, Hofland LJ, Brabander T, Eskens FALM, Moreno MAG, Luque RM, Castano JP, de Herder WW, Feelders RA; Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives. DRUGS. 2019 Jan;79(1):21-42. doi: 10.1007/s40265-018-1033-0.
IF: 4,993 Q: 1
Herrera-Martinez AD, van den Dungen R, Dogan-Oruc F, van Koetsveld PM, Culler MD, de Herder WW, Luque RM, Feelders RA, Hofland LJ; Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors. ENDOCRINE-RELATED CANCER. 2019 Jun;26(6):585-599. doi: 10.1530/ERC-19-0086.
IF: 4,774 Q; 1
Frantzi M, Gomez EG, Pedregosa AB, Rosa JV, Latosinska A, Culig Z, Merseburger AS, Luque RM, Tapia MJR, Mischak H, Valiente JC; CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer. BRITISH JOURNAL OF CANCER. 2019 Jun;120(12):1120-1128. doi: 10.1038/s41416-019-0472-z.
IF: 5,416 Q: 1
Gomez-Gomez E, Carrasco-Valiente J, Campos-Hernandez JP, Blanca-Pedregosa AM, Jimenez-Vacas JM, Ruiz-Garcia J, Valero-Rosa J, Luque RM, Requena-Tapia MJ; Clinical association of metabolic syndrome, C-reactive protein and testosterone levels with clinically significant prostate cancer. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2019 Feb;23(2):934-942. doi: 10.1111/jcmm.13994.
IF: 4,658 Q: 1
Venegas-Moreno E, Flores-Martinez A, Dios E, Vazquez-Borrego MC, Ibanez-Costa A, Madrazo-Atutxa A, Japon MA, Castano JP, Luque RM, Cano DA, Soto-Moreno A; E-cadherin expression is associated with somatostatin analogue response in acromegaly. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE.2019 May;23(5):3088-3096. doi: 10.1111/jcmm.13851.
IF: 4,658 Q: 1
Borque-Fernando A, Rubio-Briones J, Esteban LM, Dong Y, Calatrava A, Gomez-Ferrer A, Gomez-Gomez E, Fabra JMG, Rodriguez-Garcia N, Gonzalez PAL, Garcia-Rodriguez J, Rodrigo-Aliaga M, Herrera-Imbroda B, Soto-Villalba J, Martinez-Breijo S, Hernandez-Canas V; Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance. PROSTATE CANCER AND PROSTATIC DISEASES. 2019 Mar;22(1):84-90. doi: 10.1038/s41391-018-0074-5.
IF: 4,6 Q: 1
Leon-Acuna A, Torres-Pena JD, Alcala-Diaz JF, Vals-Delgado C, Roncero-Ramos I, Yubero-Serrano E, Tinahones FJ, Castro-Clerico M, Delgado-Lista J, Ordovas JM, Lopez-Miranda J, Perez-Martinez P; Lifestyle factors modulate postprandial hypertriglyceridemia: From the CORDIOPREV study. ATHEROSCLEROSIS. 2019 Nov;290:118-124. doi: 10.1016/j.atherosclerosis.2019.09.025
IF: 4,255 Q: 1
Coelho MCA, Vasquez ML, Wildemberg LE, Vazquez-Borrego MC, Bitana L, Camacho AHD, Silva D, Ogino LL, Ventura N, Sanchez-Sanchez R, Chimelli L, Kasuki L, Luque RM, Gadelha MR; Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles. SCIENTIFIC REPORTS. 2019 Feb 4;9(1):1122. doi: 10.1038/s41598-018-37692-3.
IF: 4,011 Q: 1
Gomez-Delgado F, Alcala-Diaz JF, Leon-Acuna A, Lopez-Moreno J, Delgado-Lista J, Gomez-Marin B, Roncero-Ramos I, Yubero-Serrano EM, Rangel-Zuniga OA, Vals-Delgado C, Luque RM, Ordovas JM, Lopez-Miranda J, Perez-Martinez P; Apolipoprotein E genetic variants interact with Mediterranean diet to modulate postprandial hypertriglyceridemia in coronary heart disease patients: CORDIOPREV study. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2019 Aug;49(8):e13146. doi: 10.1111/eci.13146.
IF: 2,784 Q: 1
Soriano S, Castellano-Munoz M, Rafacho A, Alonso-Magdalena P, Marroqui L, Ruiz-Pino A, Bru-Tari E, Merino B, Irles E, Bello-Perez M, Iborra P, Villar-Pazos S, Vettorazzi JF, Montanya E, Luque RM, Nadal A, Quesada I; Cortistatin regulates glucose-induced electrical activity and insulin secretion in mouse pancreatic beta-cells. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2019 Jan 5;479:123-132. doi: 10.1016/j.mce.2018.09.009.
IF: 3,693 Q: 2
Blanca A, Sanchez-Gonzalez A, Requena MJ, Carrasco-Valiente J, Gomez-Gomez E, Cheng L, Cimadamore A, Montironi R, Lopez-Beltran A; Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer. APMIS. 2019 Aug;127(8):545-553. doi: 10.1111/apm.12973.
IF: 2,225 Q: 2
Fuentes-Fayos AC, Garcia-Martinez A, Herrera-Martinez AD, Jimenez-Vacas JM, Vazquez-Borrego MC, Castano JP, Pico A, Gahete MD, Luque RM; Molecular determinants of the response to medical treatment of growth hormone secreting pituitary neuroendocrine tumors. MINERVA ENDOCRINOLOGICA. 2019 Jun;44(2):109-128. doi: 10.23736/S0391-1977.19.02970-5.
IF: 1,817 Q: 4
Juárez-Soto A, Garín-Ferreira JM, Rodríguez-Fernández A, Tirado-Hospital JL, González-Serrano MT, Moreno-Jiménez J, Medina-López R, Baena-González V. Diagnosis of metastasis in castration-resistant prostate cancer patients: decision algorithm in imaging tests. ACTAS UROLOGICAS ESPANOLAS. 2019 Mar;43(2):55-61. doi: 10.1016/j.acuro.2018.05.011
IF: 1,136 D: 2
Gomez Gomez E, Salamanca Bustos JJ, Carrasco Valiente J, Fernandez Rueda JL, Blanca A, Valero Rosa J, Bravo Arrebola I, Marquez López J, Jimenez Vacas JM, Luque R, Requena Tapia MJ. Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL. BRITISH MEDICAL JOURNAL OPEN. 2019 Nov 12;9(11):e031032. doi: 10.1136/bmjopen-2019-031032.
IF: 2,376 D: 2
Gómez-Gómez E, Carrasco-Valiente J, Campos-Hernández JP, Blanca-Pedregosa AM, Jiménez-Vacas JM, Ruiz-García J, Valero-Rosa J, Luque RM, Requena-Tapia MJ. Clinical association of metabolic syndrome, C-reactive protein and testosterone levels with clinically significant prostate cancer. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2019 Feb;23(2):934-942. doi: 10.1111/jcmm.13994.
IF: 4,658 Q: 1
Publications in 2018
Gahete MD, Del Rio-Moreno M, Camargo A, Alcala-Diaz JF, Alors-Perez E, Delgado-Lista J, Reyes O, Ventura S, Perez-Martínez P, Castaño JP, Lopez-Miranda J, Luque RM. Changes in Splicing Machinery Components Influence, Precede, and Early Predict the Development of Type 2 Diabetes: From the CORDIOPREV Study. EBioMedicine 2018, 3964(18)30479-1.
IF: 6.680 Q: 1 D: 1
Vázquez-Borrego MC, Fuentes-Fayos AC, Gahete MD, Castaño JP, Kineman RD, Luque RM. The pituitary gland is a novel major site of action of metformin in non-human primates: A potential path to expand and integrate its metabolic actions. Cell Physiol Biochem 2018, 49(4):1444-1459.
IF: 5.500 Q: 1 D: 1
Gómez-Gómez E, Jiménez-Vacas JM, Carrasco-Valiente J, Herrero-Aguayo V, Blanca-Pedregosa AM, León-González AJ, Valero-Rosa J, Fernández-Rueda JL, González-Serrano T, López-Miranda J, Gahete MD, Castaño JP, Requena-Tapia MJ, Luque RM. Plasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancer. J Cell Mol Med 2018, 22(11):5688-5697.
IF: 4.658 Q: 1
Herrera-Martínez AD, Gahete MD, Sánchez-Sánchez R, Alors-Perez E, Pedraza-Arevalo S, Serrano-Blanch R, Martínez-Fuentes AJ, Gálvez-Moreno MA, Castaño JP, Luque RM. Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors. Clin Transl Gastroenterol 2018, 9(10):196.
IF: 4.803 Q: 1
Gahete MD, Jimenez-Vacas JM, Alors-Perez E, Herrero-Aguayo V, Fuentes-Fayos AC, Pedraza-Arevalo S, Castano JP, Luque RM; Mouse models of endocrine tumors. J Endocrinol. 2018 Nov 1. pii: JOE-18-0571.R1.
IF: 4,381 Q: 1
Alhambra-Expósito MR, Ibáñez-Costa A, Moreno-Moreno P, Rivero-Cortés E, Vázquez-Borrego MC, Blanco-Acevedo C, Toledano-Delgado Á, Lombardo-Galera MS, Vallejo-Casas JA, Gahete MD, Castaño JP, Gálvez MA, Luque RM. Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas. Sci Rep 2018, 8(1):6173.
IF: 4.011 Q: 1
Venegas-Moreno E, Vazquez-Borrego MC, Dios E, Gros-Herguido N, Flores-Martinez A, Rivero-Cortes E, Madrazo-Atutxa A, Japon MA, Luque RM, Castano JP, Cano DA, Soto-Moreno A. Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly. J Cell Mol Med 2018, 22(3)1640-1649.
IF: 4.658 Q: 1
Alves-Coelho MC, Vasquez ML, Wildemberg LE, Vazquez-Borrego MC, Bitana L, Camacho AHD, Silva D, Ogino LL, Ventura N, Chimelli L, Luque RM, Kasuki L, Gadelha MR. Molecular evidence and clinical importance of beta-arrestins expression in patients with a cromegaly. J Cell Mol Med 2018, 22(4)2110-2116.
IF: 4.658 Q: 1
Herrera-Martínez AD, Gahete MD, Pedraza-Arévalo S, Sánchez-Sánchez R, Ortega-Salas R, Serrano-Blanch R, Luque RM, Gálvez-Moreno MA, Castaño JP. Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors. Endocrine 2018, 59(2):426-437.
IF: 3.296 Q: 2
Vázquez-Borrego MC, Gahete MD, Martínez-Fuentes AJ, Fuentes-Fayos AC, Castaño JP, Kineman RD, Luque RM. Review. Multiple signaling pathways convey central and peripheral signals to regulate pituitary function: lessons from human and non-human primate models. Mol Cell Endocrinol 2018, 463:4-22.
IF: 3.693 Q: 2
Rincón-Fernández D, Culler MD, Tsomaia N, Moreno-Bueno G, Luque RM, Gahete MD, Castaño JP. In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines. Carcinogenesis 2018, 39(3):447-457.
IF: 4.004 Q: 2
Luque RM, Kineman RD. Neuronostatin exerts actions on pituitary that are unique from its sibling peptide somatostatin. J Endocrinol 2018, 237(3):217-227.
IF: 4.381 Q: 1
Pedraza-Arevalo S, Gahete MD, Alors-Perez E, Luque RM, CastanoJP. Multilayered heterogeneity as an intrinsic hallmark of neuroendocrinetumors. Rev Endocr Metab Disord 2018, 19(2)179-192.
IF: 5. 516 Q: 1
Jimenez-Lucena R, Camargo A, Alcala-Diaz JF, Romero-Baldonado C, Luque RM, van Ommen B, Delgado-Lista J, Ordovas JM, Perez-Martinez P, Rangel-Zuniga OA, Lopez-Miranda J. A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study. Exp Mol Med 2018, 50(12):168.
IF: 4.743 Q: 1
Leon-Gonzalez AJ, Navarro I, Acero N, Mingarro DM, Martin-Cordero C. Genus Retama: a review on traditional uses, phytochemistry, and pharmacological activities. Phytochem Rew 2018, 17(4)701-731.
IF: 4.257 Q: 1 D: 1
Gomez-Gomez E, Rosa JV, Valiente JC, Tarradas FT, Curado FA, Ruiz DL, Tapia MJ. New Approach to Guide Target Prostate Biopsy: Technique and Initial Experience. Urology 2018, 121()198-199.
IF: 1.861 Q: 2
Cordoba-Chacon J, Sarmento-Cabral A, del Rio-Moreno M, Diaz-Ruiz A, Subbaiah PV, KinemanRD. Adult-Onset Hepatocyte GH Resistance Promotes NASH in Male Mice, Without Severe Systemic Metabolic Dysfunction. Endocrinology 2018, 159(11)3761-3774.
IF: 3.800 Q: 2
Salamanca-Bustos JJ, Gomez-Gomez E, Campos-Hernandez JP, Carrasco-Valiente J, Ruiz-Garcia J, Marquez-Lopez FJ, Zurera-Tendero L, Requena-Tapia MJ. Initial Experience in the Use of Novel Auto-expandable Metal Ureteral Stent in the Treatment of Ureter Stenosis in Kidney Transplanted Patients. Transplantation Proceedings 2018, 50(2)587-590.
IF: 0.959 Q: 4
